Apyx Medical (APYX) Non-Current Debt (2010 - 2026)

Apyx Medical (APYX) has reported Non-Current Debt for 14 consecutive years, with $35.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt rose 2.8% year-over-year to $35.3 million; the trailing twelve-month figure through Jun 2026 stood at $35.3 million (up 2.8% YoY), and the FY2025 full-year result was $34.8 million, up 2.82% from the prior year.
• Non-Current Debt grew to $35.3 million in Q2 2026 per APYX's latest filing, from $35.1 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $35.3 million in Q2 2026 and bottomed at $8.8 million in Q1 2023.
• Historically, Non-Current Debt has averaged $28.8 million across 4 years, with a median of $33.9 million in 2024.
• The widest YoY moves for Non-Current Debt: up 280.57% in 2024, down 2.13% in 2024.
• Over 4 years, Non-Current Debt stood at $33.2 million in 2023, then gained by 2.13% to $33.9 million in 2024, then grew by 2.82% to $34.8 million in 2025, then gained by 1.37% to $35.3 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $35.3 million, $35.1 million, and $34.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.